The purpose of External Quality Assessment is to compare performance of individual laboratories or test centres with their peers. EQA is a retrospective form of quality control - participants do not know the target range or expected results for their test, unlike internal quality control.
Target values
Performance for the Emicizumab programme is based on the use of the assay result (µg/ml) to determine the z score, calculated as follows. The central reference
point is taken as the peer group median. The robust mean and SD are calculated by statistical exclusion of outlying results. The z-score is then calculated as
[participant result – mean] / SD
A z-score between -2 and +2 is deemed ‘within consensus’. A z score >+/-2 is considered outwith consensus (warning); a z-score of >+/-3 is considered outwith consensus (action required).
Performance is determined by comparison of individual laboratory results with the target value for each test. UK NEQAS BC uses median values determined from
participants' results to determine the consensus or "target" values against which individual laboratory performance can be assessed. Use of the median avoids the effect of outlying results and the
need to remove any outlying data from the analysis.
Terminology
Results are assessed using statistical measures comparing individual results with peer group or overall consensus values. Therefore, a result falling outside the
statistically defined terms is not necessarily a "poor" or "unsatisfactory" result. We deliberately employ the term "outwith consensus" to indicate a result that falls outside the statistically
determined limits we have applied.
|
|
|
|